PL2475764T3 - Niezdolny do przeżycia materiał otrzymany z probiotyku do zapobiegania i leczenia alergii - Google Patents

Niezdolny do przeżycia materiał otrzymany z probiotyku do zapobiegania i leczenia alergii

Info

Publication number
PL2475764T3
PL2475764T3 PL10757324T PL10757324T PL2475764T3 PL 2475764 T3 PL2475764 T3 PL 2475764T3 PL 10757324 T PL10757324 T PL 10757324T PL 10757324 T PL10757324 T PL 10757324T PL 2475764 T3 PL2475764 T3 PL 2475764T3
Authority
PL
Poland
Prior art keywords
treatment
derived non
allergy prevention
viable material
probiotic derived
Prior art date
Application number
PL10757324T
Other languages
English (en)
Inventor
Tol Eric A.F. Van
William Michael Russell
Udo Herz
Harald Renz
Holger Garn
Machtelt Braaksma
Der Werf Maria Johanna Van
Karin M. Overkamp
Original Assignee
Mjn U.S. Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn U.S. Holdings Llc filed Critical Mjn U.S. Holdings Llc
Publication of PL2475764T3 publication Critical patent/PL2475764T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10757324T 2009-09-11 2010-09-10 Niezdolny do przeżycia materiał otrzymany z probiotyku do zapobiegania i leczenia alergii PL2475764T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09170124A EP2295535A1 (en) 2009-09-11 2009-09-11 Probiotic material
EP10757324.8A EP2475764B1 (en) 2009-09-11 2010-09-10 Probiotic derived non-viable material for allergy prevention and treatment

Publications (1)

Publication Number Publication Date
PL2475764T3 true PL2475764T3 (pl) 2017-06-30

Family

ID=41561153

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10757324T PL2475764T3 (pl) 2009-09-11 2010-09-10 Niezdolny do przeżycia materiał otrzymany z probiotyku do zapobiegania i leczenia alergii

Country Status (20)

Country Link
US (1) US20110217402A1 (pl)
EP (2) EP2295535A1 (pl)
JP (1) JP2013504321A (pl)
KR (1) KR20120061836A (pl)
CN (1) CN102575224A (pl)
AU (1) AU2010293145B2 (pl)
BR (1) BR112012005533A2 (pl)
CA (1) CA2772593C (pl)
EC (1) ECSP12011786A (pl)
ES (1) ES2614929T3 (pl)
IN (1) IN2012DN00951A (pl)
MX (1) MX345077B (pl)
MY (1) MY160646A (pl)
NZ (1) NZ597818A (pl)
PE (1) PE20121557A1 (pl)
PL (1) PL2475764T3 (pl)
RU (1) RU2012114190A (pl)
SG (1) SG178230A1 (pl)
TW (1) TWI595090B (pl)
WO (1) WO2011031149A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130095189A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Composition and method of phytonutrients for metabolic programming effects
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
WO2015177246A2 (en) * 2014-05-20 2015-11-26 Biogaia Ab Neonatal microbiome supplementation
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
JP7057059B2 (ja) 2016-08-22 2022-04-19 株式会社明治 ラクトバチルス・プランタラムの培養物の製造方法
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
EP3708188A4 (en) * 2017-11-07 2021-12-01 HuBit genomix, Inc. METHOD FOR INHIBITING THE ACQUISITION OF AN ALLERGIC PREDISPOSITION IN THE INFANT PHASE BY SUPPRESSING IGE CLASS-SPECIFIC IMMUNE-REACTIVITY
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions
JP7828338B2 (ja) * 2020-10-16 2026-03-11 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳児又は低年齢の小児用フォーミュラ
CN119040223B (zh) * 2024-11-01 2025-02-28 微康益生菌(苏州)股份有限公司 一种具有抗炎抗敏功效的鼠李糖乳酪杆菌rh22及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
WO1992012711A1 (en) 1991-01-24 1992-08-06 Martek Corporation Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506389B2 (en) 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
US6051552A (en) * 1996-05-30 2000-04-18 Urex Biotech, Inc. Lactobacillus therapies
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
AU4905300A (en) * 1999-05-25 2000-12-12 Andrew W. Bruce Oral administration of lactobacillus for the maintenance of health in women
AU2001284558B2 (en) 2000-08-08 2007-01-04 Genesis Research And Development Corporation Limited Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
EP1458247B1 (en) * 2001-12-20 2014-01-22 Biolactis Inc. Malleable protein matrix and uses thereof
CA2508712A1 (en) * 2002-12-13 2004-07-01 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
WO2004112507A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
WO2005112976A2 (en) * 2004-04-20 2005-12-01 The University Of Chicago Probiotic compounds from lactobacillus gg and uses therefor
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233772A1 (en) * 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
WO2008052035A1 (en) * 2006-10-24 2008-05-02 Vanderbilt University Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
CA2682730A1 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
WO2009137159A2 (en) * 2008-04-17 2009-11-12 Trustees Of Dartmouth College Bioactive molecules produced by probiotic bacteria and methods for isolating and using the same

Also Published As

Publication number Publication date
CA2772593A1 (en) 2011-03-17
BR112012005533A2 (pt) 2016-04-26
PE20121557A1 (es) 2012-11-21
MY160646A (en) 2017-03-15
ES2614929T3 (es) 2017-06-02
SG178230A1 (en) 2012-03-29
WO2011031149A1 (en) 2011-03-17
KR20120061836A (ko) 2012-06-13
TW201124529A (en) 2011-07-16
CA2772593C (en) 2018-11-27
EP2295535A1 (en) 2011-03-16
AU2010293145B2 (en) 2016-04-14
JP2013504321A (ja) 2013-02-07
MX2012002716A (es) 2012-04-19
CN102575224A (zh) 2012-07-11
ECSP12011786A (es) 2012-07-31
NZ597818A (en) 2014-01-31
AU2010293145A1 (en) 2012-03-08
IN2012DN00951A (pl) 2015-04-10
RU2012114190A (ru) 2013-10-20
EP2475764B1 (en) 2016-12-14
MX345077B (es) 2017-01-16
TWI595090B (zh) 2017-08-11
US20110217402A1 (en) 2011-09-08
EP2475764A1 (en) 2012-07-18

Similar Documents

Publication Publication Date Title
BR112012005533A2 (pt) material não viável derivado de probiótijco para prevenção e tratamento de alegria
SG11201404378XA (en) Probiotic derived non-viable material for infection prevention and treatment
PL2475626T3 (pl) Materiał i oszklenie zawierające wspomniany materiał
SG10201503351RA (en) Engineered Opsonin for Pathogen Detection and Treatment
IL213072A0 (en) Microorganism comprising particles and uses of same
GB201011771D0 (en) Biological material and particular uses thereof
ZA201106702B (en) Sceletium extract and uses thereof
GB0921001D0 (en) Products and uses
GB0921481D0 (en) Process and product
GB0904825D0 (en) Biological materials and uses thereof
PL2493930T3 (pl) Udoskonalone przeciwciała przeciwko ludzkiej fraktalkinie i ich zastosowania
IL214355A0 (en) Antibodies against human tweak and uses thereof
GB201001717D0 (en) Disinfectant materials and methods
PL2406280T3 (pl) Materiały biologiczne oraz ich zastosowania
GB201009976D0 (en) Material and process
GB0912744D0 (en) Methods and uses
PL2389484T3 (pl) Produkt geosyntetyczny i sposób wykorzystania produktu geosyntetycznego
PL2292852T3 (pl) Armatura sanitarna i pierścień uszczelniający do armatury sanitarnej
GB0915794D0 (en) Screening method and treatment
EP2427766A4 (en) HUMAN GENE FG01 AND ITS APPLICATIONS
GB0921525D0 (en) Product and method
EP2385840A4 (en) MATERIALS AND METHOD FOR TREATING BLOOD HIGH PRESSURE
GB0922143D0 (en) Biological materials and uses thereof
EP2563517A4 (en) TREATMENT OF MATERIAL AND APPARATUS
GB0906634D0 (en) Bacterium and enzyme